{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:05:11Z","timestamp":1793657111741,"version":"4.5.1"},"reference-count":451,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009954","name":"MaculaFonds","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009954","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Retina Netherlands"},{"name":"BlindenPenning"},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UitZicht","id":[{"id":"https:\/\/ror.org\/05r1tfa82","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Haagse Stichting Blindenhulp","id":[{"id":"https:\/\/ror.org\/01kczb637","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ZonMw VENI Grant"},{"name":"Gisela Thier Fellowship of Leiden University","id":[{"id":"https:\/\/ror.org\/027bh9e22","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.preteyeres.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:26:54Z","timestamp":1563218814000},"page":"100770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":449,"special_numbering":"C","title":["Central serous chorioretinopathy: Towards an evidence-based treatment guideline"],"prefix":"10.1016","volume":"73","author":[{"given":"Thomas J.","family":"van Rijssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H.C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ohno-Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.E.","family":"Keunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier O.","family":"Schlingemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel B.","family":"Hoyng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice Cardillo","family":"Piccolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay K.","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Bailey","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J.F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2019.07.003_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fendo.2016.00154","article-title":"Choroidal and retinal abnormalities by optical coherence tomography in endogenous cushing's syndrome","volume":"7","author":"Abalem","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/OPTH.S87499","article-title":"Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy","volume":"9","author":"Abd Elhamid","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/jop.2014.0173","article-title":"Treatment of chronic central serous chorioretinopathy with oral methotrexate","volume":"31","author":"Abrishami","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/IAE.0000000000001040","article-title":"Choroidal vascularity index in central serous chorioretinopathy","volume":"36","author":"Agrawal","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib5","first-page":"96","article-title":"Topical nepafenac in treatment of acute central serous chorioretinopathy","volume":"2","author":"Alkin","year":"2013","journal-title":"Med. Hypothesis, Discov. Innovation (MEHDI) Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2147\/OPTH.S58617","article-title":"Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"8","author":"Alkin","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/OPTH.S112431","article-title":"Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy","volume":"10","author":"Ambiya","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICB.0b013e3182733d6b","article-title":"The seasick choroid: a finding on enhanced depth imaging spectral-domain optical coherence tomography of choroidal lymphoma","volume":"7","author":"Arias","year":"2013","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/aos.13838","article-title":"Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy","volume":"96","author":"Arif","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2003.11.059","article-title":"Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-tap and vip report no. 3","volume":"137","author":"Arnold","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cxo.12818","article-title":"Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy","volume":"102","author":"Arora","year":"2018","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/02713680903428306","article-title":"Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study","volume":"35","author":"Artunay","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jovr.jovr_9_17","article-title":"Subthreshold continuous wave autofluorescence-controlled laser treatment of chronic central serous chorioretinopathy","volume":"13","author":"Ashraf","year":"2018","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/jop.2012.0072","article-title":"The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy","volume":"29","author":"Aydin","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200402000-00001","volume":"24","author":"Azab","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2013.09.024","article-title":"Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial","volume":"121","author":"Bae","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2011.04.008","article-title":"A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy","volume":"152","author":"Bae","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib19","first-page":"118","article-title":"Prevalence of helicobacter pylori infection in patients with central serous chorioretinopathy: a review","volume":"6","author":"Bagheri","year":"2017","journal-title":"Med. Hypothesis, Discov. Innovation (MEHDI) Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajo.2012.09.018","article-title":"Serous macular detachment in waldenstrom macroglobulinemia: a report of four cases","volume":"155","author":"Baker","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ophtha.2016.03.017","article-title":"Bullous variant of central serous chorioretinopathy: expansion of phenotypic features using multimethod imaging","volume":"123","author":"Balaratnasingam","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2005.01027.x","article-title":"Long-term macular function in eyes with central serous chorioretinopathy","volume":"33","author":"Baran","year":"2005","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib23","first-page":"1131","article-title":"In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy","volume":"11","author":"Bazzazi","year":"2015","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00347-012-2688-7","article-title":"[treatment of central serous chorioretinopathy: micropulse photocoagulation versus bevacizumab]","volume":"109","author":"Beger","year":"2012","journal-title":"Der Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/IAE.0b013e3182670fa3","article-title":"Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy","volume":"33","author":"Behnia","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0002-9394(02)01694-X","article-title":"Macular infarction after transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration","volume":"134","author":"Benner","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bjo.39.10.605","article-title":"Central serous retinopathy","volume":"39","author":"Bennett","year":"1955","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.preteyeres.2018.12.003","article-title":"On the origin of proteins in human drusen: the meet, greet and stick hypothesis","volume":"70","author":"Bergen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (amd): relationships between the photoreceptor\/retinal pigment epithelium\/bruch's membrane\/choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/IAE.0b013e3181c596f8","article-title":"Subretinal fluid in acute posterior multifocal placoid pigment epitheliopathy","volume":"30","author":"Birnbaum","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0031-1299165","article-title":"New guidelines in the treatment of persistent central serous chorioretinopathy: pdt with half-dose verteporfin","volume":"229","author":"Boni","year":"2012","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","article-title":"The spectrum of ocular phenotypes caused by mutations in the best1 gene","volume":"28","author":"Boon","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2012.09.057","article-title":"Autosomal recessive bestrophinopathy: differential diagnosis and treatment options","volume":"120","author":"Boon","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","article-title":"Oct angiography and evaluation of the choroid and choroidal vascular disorders","volume":"67","author":"Borrelli","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib35","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib36","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2016.02.012","article-title":"Shift work: a risk factor for central serous chorioretinopathy","volume":"165","author":"Bousquet","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2018.09.034","article-title":"Predictive factors of response to mineralocorticoid receptor antagonists in nonresolving central serous chorioretinopathy","volume":"198","author":"Bousquet","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib39","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archopht.1993.01090090081024","article-title":"Central serous chorioretinopathy in endogenous hypercortisolism","volume":"111","author":"Bouzas","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/aos.13059","article-title":"Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study","volume":"94","author":"Breukink","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/aos.12938","article-title":"Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol","volume":"94","author":"Breukink","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib43","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1167\/iovs.15-17343","article-title":"Genomic copy number variations of the complement component c4b gene are associated with chronic central serous chorioretinopathy","volume":"56","author":"Breukink","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib44","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1167\/iovs.18-25054","article-title":"The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy","volume":"59","author":"Brinks","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.08-1779","article-title":"In vivo human choroidal thickness measurements: evidence for diurnal fluctuations","volume":"50","author":"Brown","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(14)73483-X","article-title":"Nadolol in the treatment of central serous retinopathy","volume":"116","author":"Browning","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0161-6420(97)30262-0","article-title":"Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up","volume":"104","author":"Burumcek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/OPTH.S12583","article-title":"Low-dose aspirin as treatment for central serous chorioretinopathy","volume":"4","author":"Caccavale","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"Ru486 (mifepristone): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib50","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2013.06.032","article-title":"Morphologic characterization of dome-shaped macula in myopic eyes with serous macular detachment","volume":"156","author":"Caillaux","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib51","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00417-016-3373-3","article-title":"Clinical experience with eplerenone to treat chronic central serous chorioretinopathy","volume":"254","author":"Cakir","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/ICB.0b013e318196b206","article-title":"Effect of ocular contusion in a patient with chronic central serous chorioretinopathy","volume":"4","author":"Cardillo Piccolino","year":"2010","journal-title":"Retin. Cases Brief Rep."},{"issue":"Pt 3","key":"10.1016\/j.preteyeres.2019.07.003_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/eye.1995.63","article-title":"Indocyanine green angiographic findings in central serous chorioretinopathy","volume":"9","author":"Cardillo Piccolino","year":"1995","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib54","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/IAE.0b013e31816b4b86","article-title":"Posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"Cardillo Piccolino","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib55","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/IAE.0b013e318175421f","article-title":"Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy","volume":"28","author":"Cardillo Piccolino","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","article-title":"The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy","volume":"139","author":"Cardillo Piccolino","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib57","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"23","author":"Cardillo Piccolino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib58","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1167\/iovs.18-23995","article-title":"Choroidal vascular reactivity in central serous chorioretinopathy","volume":"59","author":"Cardillo Piccolino","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib59","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","article-title":"Corticosteroids and central serous chorioretinopathy","volume":"109","author":"Carvalho-Recchia","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000444328","article-title":"Short-term retinal sensitivity and metamorphopsia changes following half-fluence photodynamic therapy in central serous chorioretinopathy","volume":"56","author":"Casalino","year":"2016","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib61","first-page":"379","article-title":"Long-term follow-up of central serous retinopathy in 150 patients","volume":"81","author":"Castro-Correia","year":"1992"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib62","first-page":"1444","article-title":"Clinical research of fenofibrate and spironolactone for acute central serous chorioretinopathy","volume":"9","author":"Chai","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib63","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/IAE.0000000000001064","article-title":"Optical coherence tomographic angiography in central serous chorioretinopathy","volume":"36","author":"Chan","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib64","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","article-title":"Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study","volume":"28","author":"Chan","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib66","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajo.2007.02.039","article-title":"Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin","volume":"143","author":"Chan","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib67","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","article-title":"Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level","volume":"87","author":"Chan","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib68","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","article-title":"Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study","volume":"42","author":"Chatziralli","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib69","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib70","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib73","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/IAE.0000000000000655","article-title":"Outcomes of treatment of choroidal neovascularization associated with central serous chorioretinopathy with intravitreal antiangiogenic agents","volume":"35","author":"Chhablani","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib74","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0000000000000804","article-title":"Antiangiogenics in choroidal neovascularization associated with laser in central serous chorioretinopathy","volume":"36","author":"Chhablani","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/OPTH.S67025","article-title":"Navigated focal laser photocoagulation for central serous chorioretinopathy","volume":"8","author":"Chhablani","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib76","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/OPTH.S86778","article-title":"Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy","volume":"9","author":"Chin","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006970","article-title":"A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy","author":"Chong","year":"2012","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5507\/bp.2013.015","article-title":"Treatment of central serous chorioretinopathy with beta-blocker metipranolol","volume":"159","author":"Chrapek","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Palacky Univ. Olomouc Czech Repub."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000484100","article-title":"Angiographic and tomographic prognostic factors of chronic central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"240","author":"Chung","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib80","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/eye.2013.236","article-title":"Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review","volume":"27","author":"Chung","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib81","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/156802608784535011","article-title":"Glucocorticoid receptor antagonists","volume":"8","author":"Clark","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib82","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0161-6420(98)91024-7","article-title":"Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome","volume":"105","author":"Cohen","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib83","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9394(86)90761-0","article-title":"Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma","volume":"101","author":"Coleman","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/631687","article-title":"Temperament and character personality profile and illness-related stress in central serous chorioretinopathy","author":"Conrad","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib85","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1124\/dmd.31.11.1448","article-title":"Pharmacokinetics and metabolism of [14c]eplerenone after oral administration to humans","volume":"31","author":"Cook","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00417-011-1900-9","article-title":"Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy","volume":"250","author":"Copete","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib87","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","article-title":"Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration","volume":"56","author":"Coscas","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2047-783X-17-22","article-title":"Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy","volume":"17","author":"Cuevas","year":"2012","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib89","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2009.05.033","article-title":"Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration","volume":"116","author":"Dadgostar","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/TCRM.S50407","article-title":"The effect of eradicating helicobacter pylori on idiopathic central serous chorioretinopathy patients","volume":"9","author":"Dang","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/TCRM.S54213","article-title":"Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy","volume":"10","author":"Dang","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib92","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1445-2197.1991.tb00230.x","article-title":"A history of photodynamic therapy","volume":"61","author":"Daniell","year":"1991","journal-title":"Aust. N. Z. J. Surg."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib94","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib95","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib96","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ophtha.2015.01.029","article-title":"Spectral-domain optical coherence tomography angiography of choroidal neovascularization","volume":"122","author":"de Carlo","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib97","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib98","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","article-title":"Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration","volume":"122","author":"de Jong","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib99","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib100","first-page":"553","article-title":"Central serous chorioretinopathy in african americans","volume":"95","author":"Desai","year":"2003","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib101","first-page":"2976","article-title":"Heat shock protein hyperexpression on chorioretinal layers after transpupillary thermotherapy","volume":"42","author":"Desmettre","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib102","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2147\/OPTH.S151933","article-title":"Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy","volume":"11","author":"Dhirani","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib103","first-page":"2592","volume":"vol. 3","author":"Duke-Elder","year":"1940"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib104","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00006982-200512000-00006","article-title":"Acute central serous chorioretinopathy and fundus autofluorescence","volume":"25","author":"Eandi","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib105","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ophtha.2014.06.038","article-title":"Visual cycle suppression via patching in central serous chorioretinopathy","volume":"121","author":"Earl","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3341\/kjo.2012.26.2.139","article-title":"Intravitreal bevacizumab for treatment of refractory central serous choroidoretinopathy","volume":"26","author":"Entezari","year":"2012","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib107","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3341\/kjo.2012.26.4.260","article-title":"Systemic factors associated with central serous chorioretinopathy in koreans","volume":"26","author":"Eom","year":"2012","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib108","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients","volume":"103","author":"Ersoz","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/jovr.jovr_139_16","article-title":"Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy","volume":"12","author":"Falavarjani","year":"2017","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ophtha.2013.10.014","article-title":"En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy","volume":"121","author":"Ferrara","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib111","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib112","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0002-9394(14)75205-5","article-title":"Central serous retinopathy in a 7-year-old girl","volume":"90","author":"Fine","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib113","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000324599","article-title":"Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy","volume":"46","author":"Fok","year":"2011","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib114","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","article-title":"Finasteride for chronic central serous chorioretinopathy","volume":"31","author":"Forooghian","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib115","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ophtha.2017.05.038","article-title":"Clinical and morphologic characteristics of mek inhibitor-associated retinopathy: differences from central serous chorioretinopathy","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib116","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jamaophthalmol.2013.5030","article-title":"Increased fundus autofluorescence related to outer retinal disruption","volume":"131","author":"Freund","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib117","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02172748","article-title":"Central serous chorioretinopathy: an analysis of the clinical morphology using image-processing techniques","volume":"227","author":"Friberg","year":"1989","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib118","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0161-6420(97)30061-X","article-title":"The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser","volume":"104","author":"Friberg","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","article-title":"One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy","volume":"122","author":"Fujita","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajo.2012.03.043","article-title":"Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"154","author":"Fujita","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib121","first-page":"1681","article-title":"Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy","volume":"6","author":"Fujita","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib122","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib123","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s003470050310","article-title":"[central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]","volume":"95","author":"Gackle","year":"1998","journal-title":"Der Ophthalmologe"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib124","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/IAE.0000000000002051","article-title":"Inner choroidal flow signal attenuation in pachychoroid disease: optical coherence tomography angiography","volume":"38","author":"Gal-Or","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib125","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy","volume":"81","author":"Garg","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00144736","article-title":"Long-term follow-up of an ophthalmologist's central serous retinopathy, photocoagulated by sungazing","volume":"66","author":"Gartner","year":"1987","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib127","article-title":"Pathogenesis of disciform detachment of the neuroepithelium: Ii. Idiopathic central serous choroidopathy","volume":"63","author":"Gass","year":"1967","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib128","first-page":"813414","article-title":"Increase in central retinal edema after subthreshold diode micropulse laser treatment of chronic central serous chorioretinopathy","author":"Gawecki","year":"2015","journal-title":"Case Rep. Ophthalmol. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib129","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00417-017-3783-x","article-title":"Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser","volume":"255","author":"Gawecki","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1176\/ajp.144.1.46","article-title":"Loss of vision due to central serous chorioretinopathy following psychological stress","volume":"144","author":"Gelber","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib131","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib132","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1111\/aos.13665","article-title":"Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy","volume":"96","author":"Gerendas","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib133","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/IAE.0000000000001303","article-title":"Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: a comparative study of exudative and nonexudative fellow eyes","volume":"37","author":"Gergely","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib134","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/IAE.0000000000000748","article-title":"Central serous chorioretinopathy treated with mineralocorticoid antagonists: a one-year pilot study","volume":"36","author":"Ghadiali","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib136","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2147\/OPTH.S16014","article-title":"Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment","volume":"5","author":"Giudice","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib137","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/eye.2014.219","article-title":"Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy","volume":"28","author":"Goktas","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib138","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1755-3768.2008.01467.x","article-title":"Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study","volume":"88","author":"Golshahi","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib139","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/eye.2015.104","article-title":"Therapeutic benefit of melatonin in refractory central serous chorioretinopathy","volume":"29","author":"Gramajo","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib141","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00006982-199717030-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome p-450 3a4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib143","series-title":"Micropulse Diode Laser Photocoagulation for Central Serous Chorio-Retinopathy","author":"Gupta","year":"2009"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib144","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10792-009-9302-2","article-title":"Morphological changes in the retinal pigment epithelium on spectral-domain oct in the unaffected eyes with idiopathic central serous chorioretinopathy","volume":"30","author":"Gupta","year":"2010","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/ICB.0000000000000105","article-title":"Long-term follow-up of photoreceptor loss and recovery after half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"9","author":"Gutierrez-Hernandez","year":"2015","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib146","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archopht.1994.01090200063023","article-title":"Digital indocyanine green videoangiography of central serous chorioretinopathy","volume":"112","author":"Guyer","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181479","article-title":"Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study","volume":"12","author":"Haga","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib148","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00417-012-2139-9","article-title":"The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy","volume":"251","author":"Hagen","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib149","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0161-6420(97)30082-7","article-title":"Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids","volume":"104","author":"Haimovici","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib151","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0161-6420(02)01975-9","article-title":"Endocrine abnormalities in patients with central serous chorioretinopathy","volume":"110","author":"Haimovici","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib152","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1167\/iovs.13-12854","article-title":"Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study","volume":"55","author":"Han","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib153","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/IAE.0b013e31826710a0","article-title":"Early changes in foveal thickness in eyes with central serous chorioretinopathy","volume":"33","author":"Hata","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00225936","article-title":"Indocyanine green angiography of central serous chorioretinopathy","volume":"9","author":"Hayashi","year":"1986","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib155","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chorioretinopathy - a case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib156","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-016-3436-5","article-title":"Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (cscr)","volume":"255","author":"Herold","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib157","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0974-620X.192288","article-title":"Flat choroidal melanoma masquerading as central serous chorioretinopathy","volume":"9","author":"Higgins","year":"2016","journal-title":"Oman J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib158","first-page":"578","article-title":"Su di una forma retinite centrale di origine vasoneurotica (retinite centrale capillaro-spastica)","volume":"55","author":"Horniker","year":"1927","journal-title":"Ann. Ottal."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib159","first-page":"487","volume":"98","author":"Horniker","year":"1937","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib160","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.1802212115","article-title":"Cfh and vipr2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy","volume":"115","author":"Hosoda","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib161","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/eye.2008.55","article-title":"Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy","volume":"23","author":"Huang","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib162","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00417-005-0175-4","article-title":"Transpupillary thermotherapy for chronic central serous chorioretinopathy","volume":"244","author":"Hussain","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib163","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/IAE.0000000000002040","article-title":"Chronic central serous chorioretinopathy: early and late morphological and functional changes after verteporfin photodynamic therapy","volume":"39","author":"Iacono","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(98)00378-X","article-title":"Plasminogen activator inhibitor 1 in central serous chorioretinopathy","volume":"127","author":"Iijima","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib166","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1167\/iovs.09-4383","article-title":"Choroidal thickness in healthy Japanese subjects","volume":"51","author":"Ikuno","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib167","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib168","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ophtha.2010.08.017","article-title":"Fundus autofluorescence and visual acuity in central serous chorioretinopathy","volume":"118","author":"Imamura","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib169","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000314709","article-title":"Results of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathy","volume":"225","author":"Inoue","year":"2011","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","article-title":"Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy","volume":"149","author":"Inoue","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib171","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bjophthalmol-2016-308921","article-title":"Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy","volume":"101","author":"Izumi","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib172","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2014.06.001","article-title":"Pathogenesis and treatment of maculopathy associated with cavitary optic disc anomalies","volume":"158","author":"Jain","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib173","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0161-6420(84)34095-7","article-title":"Retinal pigment epithelium decompensation. I. Clinical features and natural course","volume":"91","author":"Jalkh","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib174","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0161-6420(02)01303-9","article-title":"Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib175","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00417-014-2789-x","article-title":"Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome","volume":"253","author":"Jang","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib176","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11096-017-0460-4","article-title":"Clinical efficacy of anti-vegf medications for central serous chorioretinopathy: a meta-analysis","volume":"39","author":"Ji","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib177","first-page":"9450297","article-title":"Poor sleep quality is the risk factor for central serous chorioretinopathy","author":"Ji","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00160764","article-title":"Transpupillary thermotherapy (ttt) by infrared irradiation of choroidal melanoma","volume":"82","author":"Journee-de Korver","year":"1992","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib179","article-title":"Selective retina therapy in patients with chronic central serous chorioretinopathy: a pilot study","volume":"95","author":"Kang","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2008-1034901","article-title":"[serous central chorioretinopathy and endogenous hypercortisolemia]","volume":"212","author":"Kapetanios","year":"1998","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib181","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000444058","article-title":"Mineralocorticoid antagonists in the treatment of central serous chorioretinopathy: a comparative analysis","volume":"56","author":"Kapoor","year":"2016","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib182","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/eye.2013.24","article-title":"Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes","volume":"27","author":"Karakus","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib183","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/OPTH.S28239","article-title":"Transpupillary thermotherapy for atypical central serous chorioretinopathy","volume":"6","author":"Kawamura","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib184","first-page":"1158","article-title":"Effect of half adult dose of oral rifampicin (300mg) in patients with idiopathic central serous chorioretinopathy","volume":"32","author":"Khan","year":"2016","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3341\/kjo.2015.29.3.160","article-title":"The association between choroidal thickness variations and response to intravitreal bevacizumab in central serous chorioretinopathy","volume":"29","author":"Kim","year":"2015","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib186","article-title":"Comparison of visual\/anatomical outcomes and recurrence rate between oral spironolactone and photodynamic therapy for nonresolving central serous chorioretinopathy","author":"Kim","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib187","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/eye.2015.58","article-title":"Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients","volume":"29","author":"Kim","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib188","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/eye.2015.215","article-title":"Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia","volume":"30","author":"Kim","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib189","first-page":"4258763","article-title":"Mineralocorticoid receptor antagonist treatment for steroid-induced central serous chorioretinopathy patients with continuous systemic steroid treatment","author":"Kim","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib190","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00417-015-2965-7","article-title":"Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy","volume":"253","author":"Kim","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib191","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2013.10.013","article-title":"Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study","volume":"157","author":"Kim","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib192","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000345495","article-title":"Intravitreal ranibizumab for acute central serous chorioretinopathy","volume":"229","author":"Kim","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib193","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2015.04.011","article-title":"Choroidal thickness changes after photodynamic therapy and recurrence of chronic central serous chorioretinopathy","volume":"160","author":"Kim","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib194","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00417-014-2926-6","article-title":"Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy","volume":"253","author":"Kim","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3341\/kjo.2017.0144","article-title":"Association of central serous chorioretinopathy with psychosocial factors is dependent on its phase and subtype","volume":"32","author":"Kim","year":"2018","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib196","first-page":"345","article-title":"Ueber klinische beobachtungen bei der in Japan h\u00e4ufig vorkommenden chorioretinitis centralis serosa","volume":"97","author":"Kitahara","year":"1936","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib197","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","article-title":"The incidence of central serous chorioretinopathy in olmsted county, Minnesota, 1980-2002","volume":"115","author":"Kitzmann","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib198","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1974.03900060257001","article-title":"Experience with nontreatment of central serous choroidopathy","volume":"91","author":"Klein","year":"1974","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib199","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ophtha.2015.10.039","article-title":"Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results","volume":"123","author":"Koizumi","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib201","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/eye.2011.282","article-title":"Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy","volume":"26","author":"Koss","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib202","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ophtha.2010.10.007","article-title":"Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator navilas","volume":"118","author":"Kozak","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib203","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0161-6420(96)30675-1","article-title":"Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys","volume":"103","author":"Kramer","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib204","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3928\/23258160-20150909-08","article-title":"Randomized clinical trial to compare micropulse photocoagulation versus half-dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy","volume":"46","author":"Kretz","year":"2015","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib205","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e31825dd281","article-title":"Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis","volume":"32","author":"Kurup","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib206","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1755-3768.1994.tb07175.x","article-title":"Diffuse chronic retinal pigment epitheliopathy and exudative retinal detachment","volume":"72","author":"Laatikainen","year":"1994","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib207","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1088\/0031-9155\/27\/11\/002","article-title":"A microwave heating technique for the hyperthermic treatment of tumours in the eye, especially retinoblastoma","volume":"27","author":"Lagendijk","year":"1982","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/08039488.2015.1041156","article-title":"Psychological factors associated with acute and chronic central serous chorioretinopathy","volume":"70","author":"Lahousen","year":"2016","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib209","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","article-title":"A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"170","author":"Lai","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2006.090282","article-title":"Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study","volume":"90","author":"Lai","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib211","first-page":"T8","article-title":"Long-term outcome of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (an american ophthalmological society thesis)","volume":"113","author":"Lai","year":"2015","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib212","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","article-title":"Efficacy and safety of ranibizumab for the treatment of choroidal neovascularization due to uncommon cause: twelve-month results of the minerva study","volume":"38","author":"Lai","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib213","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/112067210801800613","article-title":"Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study","volume":"18","author":"Lanzetta","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib214","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IAE.0000000000000340","article-title":"Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy","volume":"35","author":"Lavinsky","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib215","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.63.10.674","article-title":"Argon laser photocoagulation in the treatment of central serous retinopathy","volume":"63","author":"Leaver","year":"1979","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib216","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/IAE.0000000000001913","article-title":"Comparison of short-term efficacy between oral spironolactone treatment and photodynamic therapy for the treatment of nonresolving central serous chorioretinopathy","volume":"39","author":"Lee","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib217","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1111\/j.1755-3768.2009.01835.x","article-title":"Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"89","author":"Lee","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib218","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","article-title":"Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy","volume":"53","author":"Lee","year":"2009","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib219","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/eye.2016.113","article-title":"Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity","volume":"30","author":"Lee","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib220","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the planet study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib221","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0000000000000287","article-title":"Pachychoroid: an inherited condition?","volume":"35","author":"Lehmann","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib222","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0161-6420(89)32810-7","article-title":"Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography","volume":"96","author":"Levine","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib223","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02656739009140948","article-title":"Localized current field hyperthermia: effect on normal ocular tissue","volume":"6","author":"Liggett","year":"1990","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib224","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib225","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00417-010-1581-9","article-title":"The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy","volume":"249","author":"Lim","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib226","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IAE.0b013e3181bcf0b4","article-title":"Intravitreal bevacizumab injection for central serous chorioretinopathy","volume":"30","author":"Lim","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib227","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s004179900110","article-title":"Familial central serous choroidopathy","volume":"238","author":"Lin","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib228","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jop.2013.0169","article-title":"Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"30","author":"Liu","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib229","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2016.04.001","article-title":"Half-dose versus half-time photodynamic therapy for central serous chorioretinopathy","volume":"167","author":"Liu","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib231","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/eye.2015.208","article-title":"Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis","volume":"30","author":"Lu","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib232","first-page":"608","article-title":"Idiopathic central serous retinopathy in China: a report of 600 cases (624 eyes) treated by acupuncture","volume":"18","author":"Lu","year":"1987","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib233","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/IAE.0000000000001005","article-title":"Low-intensity\/high-density subthreshold diode micropulse laser for central serous chorioretinopathy","volume":"36","author":"Luttrull","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib234","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/IAE.0000000000000285","article-title":"Low-intensity\/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy","volume":"35","author":"Malik","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/112067210501500219","article-title":"Bilateral serous macular detachment as a presenting feature of acute lymphoblastic leukemia","volume":"15","author":"Malik","year":"2005","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib236","first-page":"266","article-title":"Is myopia a protective factor against central serous chorioretinopathy?","volume":"9","author":"Manayath","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib237","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/23258160-20170329-08","article-title":"Low fluence photodynamic therapy versus graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy: results from a prospective study","volume":"48","author":"Manayath","year":"2017","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib238","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3928\/15428877-20120618-06","article-title":"Graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy","volume":"43","author":"Manayath","year":"2012","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib239","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF02169203","article-title":"New hypotheses on the pathogenesis and treatment of serous retinal detachment","volume":"226","author":"Marmor","year":"1988","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib240","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/IAE.0b013e31822bf6b1","article-title":"One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy","volume":"31","author":"Maruko","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib241","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib242","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184112","article-title":"Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy","volume":"12","author":"Maruko","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib243","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000001729","article-title":"Risk factors for recurrences of central serous chorioretinopathy","volume":"38","author":"Matet","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib244","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0377-1237(09)80092-0","article-title":"Role of transpupillary thermotherapy in central serous chorio-retinopathy","volume":"65","author":"Mathur","year":"2009","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib245","first-page":"605","article-title":"Macular diseases: clinical manifestations","volume":"69","author":"Maumenee","year":"1965","journal-title":"Trans. Am. Acad. Ophthalmol. Otolaryngol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib246","first-page":"801","article-title":"Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy","volume":"6","author":"Mazzolani","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib247","first-page":"939","article-title":"Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study","volume":"7","author":"Mazzolani","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib248","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib249","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib250","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2016-309247","article-title":"Preferred practice pattern in central serous chorioretinopathy","volume":"101","author":"Mehta","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib251","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","article-title":"Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy","volume":"27","author":"Meyerle","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib252","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.1989.01070020598048","article-title":"Ferromagnetic hyperthermia and iodine 125 brachytherapy in the treatment of choroidal melanoma in a rabbit model","volume":"107","author":"Mieler","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib253","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","article-title":"Common variants in the complement factor h gene confer genetic susceptibility to central serous chorioretinopathy","volume":"121","author":"Miki","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib254","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1167\/iovs.18-25497","article-title":"Genome-wide association study to identify a new susceptibility locus for central serous chorioretinopathy in the Japanese population","volume":"59","author":"Miki","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archopht.1993.01090060145039","article-title":"Photodynamic therapy of subretinal neovascularization in the monkey eye","volume":"111","author":"Miller","year":"1993","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib256","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0161-6420(91)32079-7","article-title":"Phthalocyanine photodynamic therapy of experimental iris neovascularization","volume":"98","author":"Miller","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib257","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archopht.1995.01100060136048","article-title":"Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin","volume":"113","author":"Miller","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib258","article-title":"Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy","author":"Mohabati","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib259","article-title":"Genetic risk factors in acute central serous chorioretinopathy","author":"Mohabati","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib260","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib261","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/OPTH.S160956","article-title":"Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib262","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/eye.2016.53","article-title":"Finasteride is effective for the treatment of central serous chorioretinopathy","volume":"30","author":"Moisseiev","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib263","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/bjo.2004.049403","article-title":"Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy","volume":"89","author":"Montero","year":"2005","journal-title":"Br. J. Ophthalmol."},{"issue":"Pt 2","key":"10.1016\/j.preteyeres.2019.07.003_bib264","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/eye.1999.41","article-title":"Clinical applications of the micropulse diode laser","volume":"13","author":"Moorman","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/IAE.0000000000000693","article-title":"Prevalence of the complement factor h and gstm1 genes polymorphisms in patients with central serous chorioretinopathy","volume":"36","author":"Moschos","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib266","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0029-1245251","article-title":"Fluorescein and indocyanine green angiography findings in b cell lymphoblastic leukemia mimicking acute central serous chorioretinopathy","volume":"227","author":"Moulin","year":"2010","journal-title":"Klin. Monatsbl\u00e4tter Augenheilkd."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib267","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib268","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00417-018-4031-8","article-title":"Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy","volume":"256","author":"Muller","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib269","first-page":"1949","article-title":"Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity","volume":"6","author":"Nair","year":"2012","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib270","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/IAE.0b013e318183589c","article-title":"Macular complications on the border of an inferior staphyloma associated with tilted disc syndrome","volume":"28","author":"Nakanishi","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib271","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.1984.01040030359038","article-title":"Experimental serous retinal detachment and focal pigment epithelial damage","volume":"102","author":"Negi","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib272","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pdpdt.2016.04.012","article-title":"Half-dose photodynamic therapy for chronic central serous chorioretinopathy: efficacy and safety outcomes in real world","volume":"14","author":"Neves","year":"2016","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib273","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/eye.2015.251","article-title":"Photodynamic therapy: current role in the treatment of chorioretinal conditions","volume":"30","author":"Newman","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib274","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib275","first-page":"1","article-title":"Central serous chorioretinopathy: clinical characteristics associated with visual outcomes","author":"Nicholson","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib276","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","article-title":"Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"157","author":"Nicolo","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib277","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","article-title":"Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy","volume":"153","author":"Nicolo","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib278","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib279","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/IAE.0000000000001645","article-title":"Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity","volume":"38","author":"Nourinia","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006982-198700730-00005","article-title":"Krypton and argon laser photocoagulation for central serous chorioretinopathy","volume":"7","author":"Novak","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib281","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41433-018-0029-z","article-title":"Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy","volume":"32","author":"Ntomoka","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib282","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-koyanagi-harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib283","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ophtha.2005.06.026","article-title":"Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy","volume":"112","author":"Ober","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib284","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/IAE.0000000000000511","article-title":"Choroidal thickness after full-fluence and half-fluence photodynamic therapy in chronic central serous chorioretinopathy","volume":"35","author":"Oh","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib285","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00417-013-2289-4","article-title":"One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis","volume":"251","author":"Ohkuma","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib286","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archopht.1995.01100030071024","article-title":"Transpupillary thermotherapy in choroidal melanomas","volume":"113","author":"Oosterhuis","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib287","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ophtha.2010.01.042","article-title":"High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy","volume":"117","author":"Ooto","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib288","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00417-010-1338-5","article-title":"Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy","volume":"248","author":"Ooto","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib289","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006982-200202000-00005","article-title":"A long-term follow-up study of severe variant of central serous chorioretinopathy","volume":"22","author":"Otsuka","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib290","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/eye.2016.79","article-title":"The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study","volume":"30","author":"Ozkaya","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib291","first-page":"3513794","article-title":"Low-fluence photodynamic therapy versus subthreshold micropulse yellow wavelength laser in the treatment of chronic central serous chorioretinopathy","author":"Ozmert","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib292","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpneuro0847","article-title":"The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders","volume":"4","author":"Pandi-Perumal","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib293","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib294","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajo.2014.04.021","article-title":"Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy","volume":"158","author":"Pang","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3341\/kjo.2014.28.4.306","article-title":"Intravitreal anti-vascular endothelial growth factor versus observation in acute central serous chorioretinopathy: one-year results","volume":"28","author":"Park","year":"2014","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib296","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-017-3672-3","article-title":"Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients","volume":"255","author":"Park","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib297","first-page":"71","article-title":"Argon laser photocoagulation in macular diseases","volume":"69","author":"Patz","year":"1971","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib298","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/IAE.0000000000001750","article-title":"Anti-vascular endothelial growth factor therapy versus photodynamic therapy in the treatment of choroidal neovascularization secondary to central serous chorioretinopathy","volume":"38","author":"Peiretti","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib299","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/IAE.0000000000000529","article-title":"Choroidal neovascularization in caucasian patients with longstanding central serous chorioretinopathy","volume":"35","author":"Peiretti","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib300","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bjo.2006.109702","article-title":"Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells","volume":"91","author":"Peters","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib301","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","article-title":"Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","volume":"37","author":"Pichi","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib302","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"Pikkel","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib303","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bjophthalmol-2014-306018","article-title":"A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the contain study","volume":"99","author":"Pitcher","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib304","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib305","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/bjo.79.10.922","article-title":"Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment","volume":"79","author":"Polak","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib306","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/archopht.116.12.1633","article-title":"Tissue effects of subclinical diode laser treatment of the retina","volume":"116","author":"Pollack","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib307","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Prunte","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib308","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1755-3768.2011.02157.x","article-title":"Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy","volume":"90","author":"Pryds","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib309","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/IAE.0b013e3182618bc5","article-title":"Foveal function and thickness after verteporfin photodynamic therapy in central serous chorioretinopathy with hyperautofluorescent subretinal deposits","volume":"33","author":"Pryds","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajo.2015.06.016","article-title":"Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography","volume":"160","author":"Quaranta-El Maftouhi","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib311","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/eye.2017.290","article-title":"Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy","volume":"32","author":"Rabiolo","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib312","first-page":"99","article-title":"The effect of helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani-Nobar","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib313","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/IAE.0000000000001649","article-title":"A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior)","volume":"38","author":"Rahimy","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib314","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.jfo.2012.05.006","article-title":"Circumscribed choroidal haemangioma mimicking chronic central serous chorioretinopathy","volume":"36","author":"Rahman","year":"2013","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib315","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3928\/23258160-20180628-03","article-title":"Predictors of outcome during eplerenone therapy in chronic central serous chorioretinopathy:A prospective, open-label pilot clinical study","volume":"49","author":"Rajesh","year":"2018","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib316","article-title":"Spironolactone as a therapeutic alternative for the bullous variant of central serous chorioretinopathy","author":"Ramos-Yau","year":"2018","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib317","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-12-20","article-title":"High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study","volume":"12","author":"Ratanasukon","year":"2012","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib318","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/112067210401400115","article-title":"Indocyanine green dye-enhanced micropulsed diode laser: a novel approach to subthreshold rpe treatment in a case of central serous chorioretinopathy","volume":"14","author":"Ricci","year":"2004","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib319","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00417-008-1014-1","article-title":"Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy","volume":"247","author":"Ricci","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib320","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamaophthalmol.2018.3293","article-title":"Association of corticosteroid use with incidence of central serous chorioretinopathy in South Korea","volume":"136","author":"Rim","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib321","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0161-6420(86)33652-2","article-title":"Argon laser photocoagulation treatment in central serous chorioretinopathy","volume":"93","author":"Robertson","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib322","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib323","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bjophthalmol-2017-311291","article-title":"Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the pan-american collaborative retina study (pacores) group","volume":"102","author":"Roca","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib324","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajo.2018.07.004","article-title":"Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flow in central serous chorioretinopathy","volume":"194","author":"Rochepeau","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3928\/23258160-20130909-08","article-title":"Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial","volume":"44","author":"Roisman","year":"2013","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib326","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1097\/IAE.0000000000001027","article-title":"Choroidal thickness changes in proliferative diabetic retinopathy treated with panretinal photocoagulation versus panretinal photocoagulation with intravitreal bevacizumab","volume":"36","author":"Roohipoor","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib327","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/08820538.2016.1182556","article-title":"Variation in visual outcome to anti-vascular endothelial growth factors in choroidal neovascular membrane developing in eyes with previously untreated versus focal laser-treated central serous chorioretinopathy","volume":"32","author":"Roy","year":"2017","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib328","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/IAE.0000000000001677","article-title":"Dysfunctional autonomic regulation of the choroid in central serous chorioretinopathy","volume":"38","author":"Roybal","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib329","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/jop.2016.0068","article-title":"Therapy rationale for mineralocorticoid-receptor antagonists, acetazolamide and a switch of therapy in nonresponders in central serous chorioretinopathy","volume":"33","author":"Rubsam","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1755-3768.2008.01408.x","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"88","author":"Ruiz-Moreno","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib331","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00417-017-3626-9","article-title":"Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy","volume":"255","author":"Russo","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib332","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/eye.2017.295","article-title":"Response of central serous chorioretinopathy evaluated by multimodal retinal imaging","volume":"32","author":"Sacconi","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib333","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/08820538.2013.793728","article-title":"Psychological distress and poor quality of life in patients with central serous chorioretinopathy","volume":"29","author":"Sahin","year":"2014","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib334","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2018-313048","article-title":"Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy","author":"Sahoo","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib335","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2012-302349","article-title":"Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy","volume":"97","author":"Saito","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib336","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1167\/iovs.15-17246","article-title":"Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy","volume":"56","author":"Saito","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib337","first-page":"CD011841","article-title":"Interventions for central serous chorioretinopathy: a network meta-analysis","author":"Salehi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib338","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jfo.2016.01.008","article-title":"[eplerenone treatment in chronic central serous chorioretinopathy]","volume":"39","author":"Sampo","year":"2016","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib339","first-page":"2257","article-title":"Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy","volume":"9","author":"Sanguansak","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib340","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0161-6420(95)30908-6","article-title":"Subretinal fibrosis in central serous chorioretinopathy","volume":"102","author":"Schatz","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib341","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9394(14)73524-X","article-title":"Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy","volume":"115","author":"Scheider","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib342","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","article-title":"Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study","volume":"136","author":"Schellevis","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib343","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib344","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","article-title":"Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration","volume":"45","author":"Schmidt-Erfurth","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib345","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/eye.2016.142","article-title":"Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"30","author":"Scholz","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib346","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A review of subthreshold micropulse laser for treatment of macular disorders","volume":"34","author":"Scholz","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib347","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000439600","article-title":"Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy","volume":"234","author":"Scholz","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib348","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/humu.22551","article-title":"Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy","volume":"35","author":"Schubert","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib349","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1111\/aos.13491","article-title":"Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study","volume":"95","author":"Schwartz","year":"2017","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib350","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10384-012-0162-3","article-title":"Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy","volume":"56","author":"Semeraro","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib351","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2010.08.019","article-title":"Microperimetric changes after photodynamic therapy for central serous chorioretinopathy","volume":"151","author":"Senturk","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib352","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00417-016-3378-y","article-title":"Circadian disturbance and idiopathic central serous chorioretinopathy","volume":"254","author":"Setrouk","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib353","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00417-018-4086-6","article-title":"Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy","volume":"256","author":"Sheptulin","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib354","series-title":"The 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases","author":"Shields","year":"2018"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib355","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0161-6420(01)00812-0","article-title":"Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib356","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib357","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3341\/kjo.2015.29.6.389","article-title":"Comparison of the clinical manifestations between acute vogt-koyanagi-harada disease and acute bilateral central serous chorioretinopathy","volume":"29","author":"Shin","year":"2015","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib358","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/IAE.0000000000000621","article-title":"Comparison of halving the irradiation time or the verteporfin dose in photodynamic therapy for chronic central serous chorioretinopathy","volume":"35","author":"Shiode","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib359","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ajo.2018.07.042","article-title":"Reply","volume":"195","author":"Shiragami","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib360","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.eye.6702449","article-title":"Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy","volume":"22","author":"Shukla","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib361","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00417-015-2989-z","article-title":"Oral rifampin treatment for longstanding chronic central serous chorioretinopathy","volume":"254","author":"Shulman","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib362","doi-asserted-by":"crossref","DOI":"10.1111\/aos.14140","article-title":"Evaluating diurnal changes in choroidal sublayer perfusion using optical coherence tomography angiography","author":"Siegfried","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib363","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib364","first-page":"310","article-title":"Oral eplerenone for the management of chronic central serous chorioretinopathy","volume":"8","author":"Singh","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib365","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bjophthalmol-2018-312435","article-title":"Discrepancy in current central serous chorioretinopathy classification","volume":"103","author":"Singh","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib366","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.survophthal.2010.02.005","article-title":"Micropulsed diode laser therapy: evolution and clinical applications","volume":"55","author":"Sivaprasad","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib367","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IAE.0b013e318280769c","article-title":"Half-fluence photodynamic therapy in chronic central serous chorioretinopathy","volume":"33","author":"Smretschnig","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib368","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajo.2012.02.031","article-title":"Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography","volume":"154","author":"Song","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib369","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/eye.2018.2","article-title":"The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging","volume":"32","author":"Soomro","year":"2018","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib370","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.87.6.704","article-title":"Psychosomatic aspects in patients with central serous chorioretinopathy","volume":"87","author":"Spahn","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib371","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/IAE.0b013e318158eca4","article-title":"Autofluorescence from the outer retina and subretinal space: hypothesis and review","volume":"28","author":"Spaide","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib372","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","article-title":"Central serous chorioretinopathy in younger and older adults","volume":"103","author":"Spaide","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib373","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib374","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib375","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib376","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02150023","article-title":"Pathogenesis of central serous retinopathy: a new working hypothesis","volume":"224","author":"Spitznas","year":"1986","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib377","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1167\/iovs.10-5917","article-title":"Non-damaging retinal phototherapy: dynamic range of heat shock protein expression","volume":"52","author":"Sramek","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib378","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bjophthalmol-2011-300183","article-title":"Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy","volume":"96","author":"Steinle","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib379","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bjo.2006.093328","article-title":"Half dose verteporfin pdt for central serous chorioretinopathy","volume":"90","author":"Stewart","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib380","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bjophthalmol-2017-311096","article-title":"Spironolactone versus observation in the treatment of acute central serous chorioretinopathy","volume":"102","author":"Sun","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib381","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0039-6257(88)90172-5","article-title":"The pregnant woman's eye","volume":"32","author":"Sunness","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib382","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10633-014-9443-0","article-title":"Occult macular dystrophy with bilateral chronic subfoveal serous retinal detachment associated with a novel rp1l1 mutation (p.S1199p)","volume":"129","author":"Takahashi","year":"2014","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib383","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/jop.2006.22.145","article-title":"The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial oct","volume":"22","author":"Tatham","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib384","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/08820538.2016.1228985","article-title":"Intravitreal bevacizumab and ranibizumab in the treatment of acute central serous chorioretihopathy: a single center retrospective study","volume":"33","author":"Tekin","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib385","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1167\/iovs.15-17140","article-title":"Oct angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy","volume":"56","author":"Teussink","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib386","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bjo.67.2.102","article-title":"Irreversible visual loss in waldenstrom's macroglobulinaemia","volume":"67","author":"Thomas","year":"1983","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib387","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajo.2015.12.024","article-title":"Choroidal thickness changes in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study","volume":"164","author":"Ting","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib388","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.05-0268","article-title":"Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy","volume":"46","author":"Tittl","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib389","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.121.7.975","article-title":"Topical fundus pulsation measurement in patients with active central serous chorioretinopathy","volume":"121","author":"Tittl","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib391","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-008-0856-x","article-title":"A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports)","volume":"246","author":"Torres-Soriano","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib392","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/IAE.0000000000000159","article-title":"Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in taiwan","volume":"34","author":"Tsai","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib393","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/OPX.0000000000000360","article-title":"Half-time photodynamic therapy for central serous chorioretinopathy","volume":"91","author":"Tsai","year":"2014","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib394","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjophthalmol-2014-305353","article-title":"Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy","volume":"99","author":"Tseng","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib395","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1167\/iovs.05-0838","article-title":"Ocular changes after photodynamic therapy","volume":"47","author":"Tzekov","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib396","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/eye.2012.66","article-title":"Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"26","author":"Uetani","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib397","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2008-322X.180700","article-title":"Intravitreal bevacizumab for treatment of central serous chorioretinopathy","volume":"11","author":"Unlu","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib398","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5935\/0004-2749.20160088","article-title":"Subfoveal choroidal thickness changes after intravitreal bevacizumab therapy for central serous chorioretinopathy","volume":"79","author":"Unlu","year":"2016","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib399","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdu169","article-title":"Transient mek inhibitor-associated retinopathy in metastatic melanoma","volume":"25","author":"Urner-Bloch","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib400","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5301\/ejo.5000790","article-title":"Chronic central serous chorioretinopathy as a presenting symptom of cushing syndrome","volume":"26","author":"van Dijk","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib401","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ophtha.2015.05.027","article-title":"Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma","volume":"122","author":"van Dijk","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib402","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00417-017-3720-z","article-title":"Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea","volume":"255","author":"van Dijk","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib403","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/ICB.0000000000000498","article-title":"Short-term findings on optical coherence tomography and microperimetry in chronic central serous chorioretinopathy patients treated with half-dose photodynamic therapy","volume":"12","author":"van Dijk","year":"2018","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib404","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib405","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/IAE.0000000000001966","article-title":"Familial central serous chorioretinopathy","volume":"39","author":"van Dijk","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib406","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamaophthalmol.2017.0245","article-title":"Association of a haplotype in the nr3c2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy","volume":"135","author":"van Dijk","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib407","first-page":"572","article-title":"Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy","volume":"97","author":"van Haalen","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib408","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fendo.2018.00039","article-title":"Cushing's syndrome and hypothalamic-pituitary-adrenal axis hyperactivity in chronic central serous chorioretinopathy","volume":"9","author":"van Haalen","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib409","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202549","article-title":"Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy","volume":"13","author":"van Rijssen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib410","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00417-018-4003-z","article-title":"Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy","volume":"256","author":"van Rijssen","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib411","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser","author":"van Rijssen","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib412","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00417-019-04333-y","article-title":"Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage","volume":"257","author":"van Rijssen","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib452","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00417-013-2270-2","article-title":"Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy","volume":"251","author":"Vasconselos","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib413","article-title":"Efficacy of oral rifampicin in chronic central serous chorioretinopathy","volume":"10","author":"Venkatesh","year":"2018","journal-title":"Ther. Adv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib414","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-4-15","article-title":"Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [isrctn84128484]","volume":"4","author":"Verma","year":"2004","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib415","first-page":"211","article-title":"Ueber centale recidiverende retinitis. v","volume":"12","author":"von Graefe","year":"1866","journal-title":"Graefes Arch. Ophthal."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib416","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000309216","article-title":"Diffuse retinal pigment epitheliopathy","volume":"185","author":"von Winning","year":"1982","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib417","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib418","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1600-0420.2005.00582.x","article-title":"Clinical characteristics of subretinal deposits in central serous chorioretinopathy","volume":"83","author":"Wang","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib419","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1034\/j.1600-0420.1999.770408.x","article-title":"Detection of shallow detachments in central serous chorioretinopathy","volume":"77","author":"Wang","year":"1999","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib420","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","article-title":"Retinal atrophy in idiopathic central serous chorioretinopathy","volume":"133","author":"Wang","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib421","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1167\/iovs.17-21825","article-title":"Peripheral vascular endothelial dysfunction in central serous chorioretinopathy","volume":"58","author":"Wang","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib422","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib423","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000050855","article-title":"Familial chronic central serous chorioretinopathy","volume":"215","author":"Weenink","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib424","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3928\/1542-8877-20050901-11","article-title":"Transpupillary thermotherapy in the treatment of central serous chorioretinopathy","volume":"36","author":"Wei","year":"2005","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41433-018-0212-2","article-title":"Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the vici randomised controlled trial","volume":"33","author":"Willcox","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib426","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7123248","article-title":"Type a behavior and elevated physiological and neuroendocrine responses to cognitive tasks","volume":"218","author":"Williams","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib427","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1002496223131","article-title":"Inhibition of membrane-bound carbonic anhydrase decreases subretinal ph and volume","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib428","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.eye.6700637","article-title":"Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy","volume":"18","author":"Wong","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib429","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001386","article-title":"Nondamaging laser therapy for treatment of central serous chorioretinopathy: what is the evidence?","volume":"37","author":"Wood","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib430","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/eye.2014.315","article-title":"Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome","volume":"29","author":"Yadav","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib431","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-a behavior and central serous chorioretinopathy","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib432","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","article-title":"Central serous chorioretinopathy: a personal perspective","volume":"149","author":"Yannuzzi","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib433","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/S0161-6420(84)34117-3","article-title":"Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy","volume":"91","author":"Yannuzzi","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib434","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","article-title":"Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study","volume":"23","author":"Yannuzzi","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (ipcv)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib436","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3928\/23258160-20150909-07","article-title":"A central hyporeflective subretinal lucency correlates with a region of focal leakage on fluorescein angiography in eyes with central serous chorioretinopathy","volume":"46","author":"Yannuzzi","year":"2015","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib437","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archopht.1996.01100130681007","article-title":"The long-term outcome of central serous chorioretinopathy","volume":"114","author":"Yap","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib438","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/02713683.2013.824986","article-title":"Obstructive sleep apnea in patients with central serous chorioretinopathy","volume":"39","author":"Yavas","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib439","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1167\/iovs.12-11382","article-title":"The comparative histologic effects of subthreshold 532- and 810-nm diode micropulse laser on the retina","volume":"54","author":"Yu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib440","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajo.2014.06.015","article-title":"Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography","volume":"158","author":"Yu","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib441","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0301-4738.57143","article-title":"Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy","volume":"57","author":"Zakir","year":"2009","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib442","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00417-016-3315-0","article-title":"Clinical efficiency of helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy","volume":"254","author":"Zavoloka","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib443","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib444","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib445","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamaophthalmol.2014.5312","article-title":"A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial","volume":"133","author":"Zhao","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib446","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/IAE.0b013e3181a6c028","article-title":"Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin","volume":"29","author":"Zhao","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2019.07.003_bib447","doi-asserted-by":"crossref","DOI":"10.1007\/s10103-019-02721-8","article-title":"A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy","author":"Zhou","year":"2019","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib448","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/17425255.2012.701617","article-title":"Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology","volume":"8","author":"Ziemssen","year":"2012","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib449","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1111\/aos.13742","article-title":"Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy","volume":"96","author":"Zola","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib450","article-title":"Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy","author":"Zola","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2019.07.003_bib451","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40123-018-0121-2","article-title":"Eplerenone versus observation in the treatment of acute central serous chorioretinopathy: a retrospective controlled study","volume":"7","author":"Zucchiatti","year":"2018","journal-title":"Ophthalmol. Ther."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946218300946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946218300946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:32:07Z","timestamp":1761172327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946218300946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":451,"alternative-id":["S1350946218300946"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central serous chorioretinopathy: Towards an evidence-based treatment guideline","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100770"}}